Business Wire | Jan 5, 2022 04:05PM EST

OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Jan. 05, 2022

MIAMI--(BUSINESS WIRE)--Jan. 05, 2022--OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 40th Annual J.P. Morgan Healthcare Conference being held virtually January 10-13, 2022. Management will be hosting one-on-one meetings with investors and will be participating in a virtual fireside chat on Wednesday, January 12th at 3:00 p.m. Eastern time.

The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health's website and accessible by clicking here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220105005859/en/

CONTACT: LHA Investor Relations Yvonne Briggs, 310-691-7100 ybriggs@lhai.com or Bruce Voss, 310-691-7100 bvoss@lhai.com